Asset Planning Services (Pennsylvania)’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
Other funds holding OREX
Asset Planning Services (Pennsylvania)'s OREX Position: Q2 2018 in Review
Asset Planning Services (Pennsylvania) sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 100 shares.
Asset Planning Services (Pennsylvania) first reported a position in OREX in Q3 2016 and held it in 7 quarters. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Asset Planning Services (Pennsylvania) reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Asset Planning Services (Pennsylvania) sold 100 Orexigen Therapeutics, Inc. shares in Q2 2018.
- Asset Planning Services (Pennsylvania) first reported a position in Orexigen Therapeutics, Inc. in Q3 2016 and held it in 7 quarters.
- Asset Planning Services (Pennsylvania)'s Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q2 2018, filed 1 Aug 2018.